A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

Genentech has announced plans to build a new biotechnology manufacturing plant in Holly Springs, North Carolina. The company, ...

The UK Government is pushing itself to become a world leader in AI-powered drug discovery with new investments and global ...

With a background in biochemistry, Erica Taylor admits her route into marketing is not common, but it has given her a unique ...

Lurbinectedin and atezolizumab performed better than atezolizumab alone as maintenance therapy for extensive-stage small cell lung cancer.

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

A fresh wave of layoffs is sweeping across Northern California, with job cuts spanning the biotech, retail, agriculture and health care sectors — signaling mounting economic pressures in the region.